Listed products
CME price limits caught out by Swiss franc surge
Exchange bins month-old rule after it led to huge spot-futures basis
Wells Fargo: clear ambition
Low leverage gives clearing newcomer a chance to expand
Regulatory caution slows India derivatives market development
India is courting global cash but barriers remain to foreign participation in market
CME fears futures clearing retreat
Leverage ratio could prompt FCMs to be more picky, warns CME's Sprague
Uneven growth in European listed markets
Multi-issuer platforms a growing alternative to listed exchanges
The future of listed derivatives
Sponsored video: Eurex Exchange-Deutsche Börse Group
Asia-specific Vix indexes fail to ignite market interest
Low volatility is acting as drag on the take-up of local indexes
EU-US split here to stay, exchange heads fear
Eurex's Preuss and CME Group's Gill warn on regulatory asymmetry
Korea clearing structure in question after HanMag trading error
Korea trading snafu casts doubt on KRX's default fund structure
Trading technology product of the year: Nasdaq OMX
Trading technology product of the year: Nasdaq OMX
Search for new OTC underlyings gets tougher
The history of the derivatives market has been punctuated by regular attempts to find new underlyings – never an easy task. But would-be innovators now face regulatory and political obstacles too. Lukas Becker reports
Inventory limits behind collapse in equity repo rates
Delta-one desks say their arbitrage business has been cut back – contributing to an unprecedented collapse in implied equity index repo rates. Inventory pressures created by bank regulation are being blamed. Matt Cameron reports
Emir flaws could see futures reporting delayed till 2015
Esma acknowledges industry concerns over delegated reporting provisions and confirms it is considering a one-year delay
Lawyers slam CFTC's "mindboggling" probe of EFS market it helped set up
The US Commodity Futures Trading Commission (CFTC) tried to regulate exchange of futures for swaps (EFS) transactions in 2004 and again in 2008. Then it tried to ban contingent EFS in 2010. All these attempts failed. Now the CFTC is investigating EFS…
OTC earthquake shaking up futures clearing
Stick or twist
Standardised OTC swaps spice up futurisation fight
Returns of the Mac
One size fits none: Industry split over futures and OTC holding periods
One size fits none
The power behind the throne: CME and the fight for futures market supremacy
It’s the biggest futures exchange in the world, so CME Group naturally has both friends and enemies. Some of its friends are very well connected – and some of its enemies claim this influence has been used to stifle competition, allowing the exchange to…
CME’s new swap future uses Goldman Sachs patent
Licensing agreement could be worth up to 20% of revenues from patented contract, and is seen as an attempt by Goldman Sachs to hedge its bets as new rules threaten OTC market profits
How to mend the Libor process
How to mend the Libor process